Form 4: Wendy Short Bartie Executes BMY Stock Vesting

EVP Wendy Short Bartie acquired 8,040 shares of Bristol Myers Squibb common stock via restricted stock unit vesting.

Summary

• Wendy Short Bartie, EVP of Corporate Affairs, acquired 8,040 shares of common stock on June 3, 2026, through the vesting of restricted stock units (RSUs).
• A total of 3,876 shares were withheld by the company to satisfy tax obligations related to the vesting event.
• Following these transactions, the reporting person holds 12,081 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents routine equity compensation vesting rather than a discretionary trade.

Positives

• The transaction reflects the standard vesting of equity-based compensation, aligning executive interests with shareholder value.

Negatives

• The company withheld 3,876 shares to cover tax liabilities, which is a standard but routine reduction in total holdings.

Risks

• No specific risks were disclosed in this filing.

Future Outlook

The filing does not provide forward-looking financial guidance.

Industry Context

StockSavvy.ai notes that this is a routine administrative filing regarding executive compensation and does not signal a change in corporate strategy or market outlook.

Comparison to Industry Standards

• The transaction follows standard corporate governance practices for equity compensation vesting in the pharmaceutical industry.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard executive compensation event.

Next Steps

• No future actions or milestones were mentioned.

Key Dates

Keywords

Bristol Myers Squibb, BMY, Insider Trading, Form 4, Equity Compensation, Restricted Stock Units